» Articles » PMID: 38633586

Santacruzamate A Alleviates Pain and Pain-Related Adverse Emotions Through the Inhibition of Microglial Activation in the Anterior Cingulate Cortex

Overview
Specialty Biochemistry
Date 2024 Apr 18
PMID 38633586
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic pain is a complex disease. It seriously affects patients' quality of life and imposes a significant economic burden on society. Santacruzamate A (SCA) is a natural product isolated from marine cyanobacteria in Panama. In this study, we first demonstrated that SCA could alleviate chronic inflammatory pain, pain-related anxiety, and depression emotions induced by complete Freund's adjuvant in mice while inhibiting microglial activation in the anterior cingulate cortex. Moreover, SCA treatment attenuated lipopolysaccharide (LPS)-induced inflammatory response by downregulating interleukin 1β and 6 (IL-1β and IL-6) and tumor necrosis factor-α (TNF-α) levels in BV2 cells. Furthermore, we found that SCA could bind to soluble epoxide hydrolase (sEH) through molecular docking technology, and the thermal stability of sEH was enhanced after binding of SCA to the sEH protein. Meanwhile, we identified that SCA could reduce the sEH enzyme activity and inhibit sEH protein overexpression in the LPS stimulation model. The results indicated that SCA could alleviate the development of inflammation by inhibiting the enzyme activity and expression of sEH to further reduce chronic inflammatory pain. Our study suggested that SCA could be a potential drug for treating chronic inflammatory pain.

References
1.
Long J, Liu H, Qiu Z, Xiao Z, Lu Z . Glabridin Therapy Reduces Chronic Allodynia, Spinal Microgliosis, and Dendritic Spine Generation by Inhibiting Fractalkine-CX3CR1 Signaling in a Mouse Model of Tibial Fractures. Brain Sci. 2023; 13(5). PMC: 10216346. DOI: 10.3390/brainsci13050739. View

2.
Zarriello S, Tuazon J, Corey S, Schimmel S, Rajani M, Gorsky A . Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders. Prog Neurobiol. 2018; 172:23-39. PMC: 6993804. DOI: 10.1016/j.pneurobio.2018.11.001. View

3.
Krebs E, Gravely A, Nugent S, Jensen A, DeRonne B, Goldsmith E . Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial. JAMA. 2018; 319(9):872-882. PMC: 5885909. DOI: 10.1001/jama.2018.0899. View

4.
Bedene A, Dahan A, Rosendaal F, van Dorp E . Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids. Expert Rev Clin Pharmacol. 2022; 15(9):1081-1094. DOI: 10.1080/17512433.2022.2114898. View

5.
Nguyen T, Nguyen N, Cochran A, Smith J, Al-Juboori M, Brumett A . Repeated closed-head mild traumatic brain injury-induced inflammation is associated with nociceptive sensitization. J Neuroinflammation. 2023; 20(1):196. PMC: 10464478. DOI: 10.1186/s12974-023-02871-1. View